| 1 |
To elect four directors to hold office until the 2027 Annual Meeting of Stockholders or until a successor is duly elected and qualified or until the director’s earlier death, resignation or removal. We refer to this proposal as the “Director Election Proposal” or “Proposal 1.” |
|
| 1.1 |
J.D. Finley |
Withhold(1202.8)
|
| 1.2 |
Donald Williams |
✓ For(1202.8)
|
| 1.3 |
Emil Chuang |
✓ For(1202.8)
|
| 1.4 |
Robert F. Baltera, Jr. |
✓ For(1202.8)
|
| 2 |
To ratify the appointment of Baker Tilly US, LLP, as our independent registered public accounting firm for the fiscal year ending December 31, 2026. We refer to this proposal as the “Auditor Ratification Proposal” or “Proposal 2.” |
✓ For(1202.8)
|
| 3 |
To approve an amendment to our Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”) to increase the number of authorized shares of common stock from 300,000,000 to 450,000,000 (which will result in an increase in the total number of authorized shares of capital stock of the Company from 307,000,000 to 457,000,000. We refer to this proposal as the “Increased Authorized Shares Proposal” or “Proposal 3.” |
✓ For(1202.8)
|
| 4 |
To approve the Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan. We refer to this proposal as the “Incentive Plan Proposal” or “Proposal 4.” |
✓ For(1202.8)
|
| 5 |
To approve the Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan. We refer to this proposal as the “Purchase Plan Proposal” or “Proposal 5.” |
✓ For(1202.8)
|
| 6 |
To approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. We refer to this proposal as the “Say-On-Pay Proposal” or “Proposal 6.” |
✓ For(1202.8)
|
| 7 |
To approve equity award grants to our non-employee directors. We refer to this proposal as the “Director Grants Proposal” or “Proposal 7.” |
✓ For(1202.8)
|
rebel Financial
